Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
Go back to Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies| Danaher Corp. (NYSE: DHR) | Delayed: 199.05 +3.07 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $195.98 | 52 Week High | $102.79 | |||
| Open | $197.58 | 52 Week Low | $75.71 | |||
| Day High | $199.84 | P/E | 52.38 | |||
| Day Low | $195.05 | EPS | $3.80 | |||
| Volume | 3,847,653 | |||||

